Does skin cholesterol testing provide benefit?
Ho C
Record ID 32002000817
English, French
Authors' objectives:
To summarise the available evidence on skin cholesterol testing.
Authors' recommendations:
- Cholesterol 1,2,3 (TM) is being promoted as a non-invasive way to measure cholesterol that has accumulated in a person's skin.
- The test received a medical device licence from Health Canada in January 2001. It was approved by the U.S. Food and Drug Administration (FDA) in June 2002.
- This test is not intended to be used as a screening tool for coronary artery disease in the general population. Evidence from non-randomized, non-blinded clinical trials suggests a correlation between higher skin cholesterol levels and the presence of severe coronary arterial lesions.
- At this point, technical improvements and more robust evidence are required to determine the significance of this technology in clinical practice.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
https://www.ccohta.ca/
Year Published:
2002
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Diagnostic Techniques and Procedures
- Skin Tests
- Cholesterol
Contact
Organisation Name:
Canadian Coordinating Office for Health Technology Assessment
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.